ALPs Single ChambEr New Device

计划入组 10 人 · 首次发布于 2026 年 3 月 10 日

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

计划入组 77 人 · 首次发布于 2003 年 9 月 9 日

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

计划入组 1,200 人 · 首次发布于 1999 年 11 月 4 日

ALPS-12

OTJ (China Health Group, Inc.)

Meningococcal group B vaccine(Pfizer Inc.)

Integrated Therapeutics Group, Inc.

United States

ACE VISION GROUP INC.

United States

K-Group Beta, Inc.

United States

Alps Group Reports Positive Safety Data for Autologous NK Cell Therapy in Nine-Patient Case Series

Alps Group Completes $1.6 Billion SPAC Merger, Lists on Nasdaq to Advance Precision Medicine Platform

Corvus Pharmaceuticals Initiates Phase 2 Trial of Soquelitinib for Rare Genetic Disease ALPS